SAN

92.04

-1.26%↓

MRK1

114.35

+0.09%↑

SHL.DE

46.49

-3.73%↓

ARGX

512.6

-0.85%↓

FRE

43.08

-0.49%↓

SAN

92.04

-1.26%↓

MRK1

114.35

+0.09%↑

SHL.DE

46.49

-3.73%↓

ARGX

512.6

-0.85%↓

FRE

43.08

-0.49%↓

SAN

92.04

-1.26%↓

MRK1

114.35

+0.09%↑

SHL.DE

46.49

-3.73%↓

ARGX

512.6

-0.85%↓

FRE

43.08

-0.49%↓

SAN

92.04

-1.26%↓

MRK1

114.35

+0.09%↑

SHL.DE

46.49

-3.73%↓

ARGX

512.6

-0.85%↓

FRE

43.08

-0.49%↓

SAN

92.04

-1.26%↓

MRK1

114.35

+0.09%↑

SHL.DE

46.49

-3.73%↓

ARGX

512.6

-0.85%↓

FRE

43.08

-0.49%↓

Search

Laboratorios Farmaceuticos Rovi SA

Închisă

SectorSănătate

51.6 -0.19

Rezumat

Modificarea prețului

24h

Curent

Minim

50.8

Maxim

52.25

Indicatori cheie

By Trading Economics

Venit

-57M

32M

Vânzări

199M

434M

P/E

Medie Sector

19.029

54.533

EPS

0.354

Randament dividend

1.8

Marjă de profit

7.411

Angajați

2,197

EBITDA

40M

138M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+50.1% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.80%

2.41%

Următoarele câștiguri

30 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-707M

2.7B

Deschiderea anterioară

51.79

Închiderea anterioară

51.6

Sentimentul știrilor

By Acuity

50%

50%

174 / 382 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

Laboratorios Farmaceuticos Rovi SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 mai 2025, 23:48 UTC

Acțiuni populare

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

22 mai 2025, 23:07 UTC

Top știri

Fortescue Energy CEO to Resign in Executive Overhaul

22 mai 2025, 23:03 UTC

Principalele dinamici ale pieței

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

22 mai 2025, 23:59 UTC

Market Talk

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

22 mai 2025, 23:45 UTC

Market Talk

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

22 mai 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

22 mai 2025, 23:23 UTC

Market Talk

Global Energy Roundup: Market Talk

22 mai 2025, 23:23 UTC

Market Talk

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

22 mai 2025, 23:12 UTC

Top știri

Supreme Court Lets Trump Fire Agency Officials, but Moves to Protect Fed -- WSJ

22 mai 2025, 21:54 UTC

Top știri

Global Finance Officials Gloss Over Trade Tensions At G-7 Summit -- WSJ

22 mai 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

22 mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 mai 2025, 20:46 UTC

Achiziții, Fuziuni, Preluări

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

22 mai 2025, 20:39 UTC

Câștiguri

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

22 mai 2025, 20:36 UTC

Top știri

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

22 mai 2025, 20:36 UTC

Top știri
Câștiguri

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

22 mai 2025, 20:32 UTC

Top știri
Câștiguri

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mai 2025, 20:27 UTC

Top știri

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

22 mai 2025, 20:20 UTC

Top știri

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mai 2025, 20:17 UTC

Top știri

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

22 mai 2025, 20:16 UTC

Câștiguri

Intchains Group 1Q Rev $18.2M >ICG

22 mai 2025, 20:15 UTC

Top știri

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mai 2025, 20:08 UTC

Top știri
Câștiguri

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mai 2025, 20:05 UTC

Top știri

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

22 mai 2025, 20:04 UTC

Câștiguri

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

22 mai 2025, 20:04 UTC

Câștiguri

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

22 mai 2025, 20:01 UTC

Câștiguri

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

22 mai 2025, 20:01 UTC

Câștiguri

Workday 1Q Net $68M >WDAY

22 mai 2025, 20:01 UTC

Câștiguri

Workday 1Q EPS 25c >WDAY

22 mai 2025, 20:01 UTC

Câștiguri

Workday 1Q Adj EPS $2.23 >WDAY

Comparație

Modificare preț

Laboratorios Farmaceuticos Rovi SA Așteptări

Obiectiv de preț

By TipRanks

50.1% sus

Prognoză pe 12 luni

Medie 77.75 EUR  50.1%

Maxim 90 EUR

Minim 65.5 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruLaboratorios Farmaceuticos Rovi SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

2

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

51.1 / N/ASuport & Rezistență

Termen scurt

Weak Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

174 / 382 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.